Our study identified exosome-associated molecules, namely SNORD91A and SLC40A1, which notably impact ESCC prognosis and local M2 macrophage recruitment, thereby presenting potential therapeutic targets for ESCC. This evidence concerns the gene SLC40A1 and esophageal squamous cell carcinoma.